Your browser is no longer supported. Please, upgrade your browser.
Settings
EGLT Egalet Corporation daily Stock Chart
EGLT [NASD]
Egalet Corporation
Index- P/E- EPS (ttm)-3.39 Insider Own0.30% Shs Outstand49.50M Perf Week-11.30%
Market Cap50.49M Forward P/E- EPS next Y-1.11 Insider Trans-13.67% Shs Float42.62M Perf Month17.92%
Income-92.20M PEG- EPS next Q-0.39 Inst Own66.40% Short Float16.50% Perf Quarter-29.17%
Sales24.50M P/S2.06 EPS this Y-26.00% Inst Trans38.99% Short Ratio5.68 Perf Half Y-61.36%
Book/sh-0.90 P/B- EPS next Y59.60% ROA-73.80% Target Price6.00 Perf Year-86.79%
Cash/sh2.06 P/C0.49 EPS next 5Y- ROE421.70% 52W Range0.80 - 10.00 Perf YTD-86.67%
Dividend- P/FCF- EPS past 5Y-51.40% ROI-89.40% 52W High-89.80% Beta0.47
Dividend %- Quick Ratio2.70 Sales past 5Y93.50% Gross Margin80.70% 52W Low27.37% ATR0.12
Employees154 Current Ratio2.70 Sales Q/Q42.60% Oper. Margin- RSI (14)45.98 Volatility6.86% 14.74%
OptionableYes Debt/Eq- EPS Q/Q58.00% Profit Margin- Rel Volume0.65 Prev Close1.02
ShortableYes LT Debt/Eq- EarningsNov 08 BMO Payout- Avg Volume1.24M Price1.02
Recom2.00 SMA20-6.95% SMA50-5.11% SMA200-54.76% Volume804,292 Change0.00%
Nov-09-17Downgrade Gabelli & Co Buy → Hold
Aug-10-17Reiterated Stifel Buy $14 → $6
May-12-17Upgrade Gabelli & Co Hold → Buy $9.50
Sep-13-16Initiated Gabelli & Co Buy $9.50
Nov-04-15Initiated Cantor Fitzgerald Buy
May-11-15Initiated Guggenheim Buy $24
Sep-24-14Reiterated Stifel Buy $20 → $18
Mar-03-14Initiated Stifel Buy $20
Dec-05-17 12:43PM  ETFs with exposure to Egalet Corp. : December 5, 2017 Capital Cube
Nov-30-17 07:00AM  Wired News Egalet Shares Positive Top-Line Results from Phase-3 Study of Egalet-002 in Patients with Chronic Low Back Pain ACCESSWIRE +5.18%
Nov-28-17 06:02AM  Egalet Announces Positive Top-Line Results from Phase 3 Study Evaluating Efficacy and Safety of Egalet-002 in Patients with Moderate-to-Severe Chronic Low Back Pain PR Newswire +9.17%
Nov-22-17 03:00PM  EGLT: Impressive Prescription Growth; Revenues Should Follow Zacks Small Cap Research
Nov-20-17 12:19PM  ETFs with exposure to Egalet Corp. : November 20, 2017 Capital Cube
06:02AM  Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian Technology PR Newswire
Nov-17-17 08:00AM  Todays Research Reports on Trending Tickers: Egalet Corporation and Intrexon Corporation ACCESSWIRE -12.61%
Nov-16-17 02:50PM  Egalet Announces Positive Top-Line Results from Phase 3 Safety Study Evaluating Safety of Egalet-002 PR Newswire +38.55%
Nov-15-17 12:17AM  Edited Transcript of EGLT earnings conference call or presentation 8-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-09-17 12:38PM  ETFs with exposure to Egalet Corp. : November 9, 2017 Capital Cube
08:53AM  Egalet Corp. :EGLT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube
Nov-08-17 06:40AM  Egalet Corporation to Host Earnings Call ACCESSWIRE
06:09AM  Egalet reports 3Q loss Associated Press
06:02AM  Egalet Announces Third Quarter 2017 Financial Results PR Newswire
Nov-06-17 06:02AM  Egalet Announces ARYMO ER Added to Large Payer Medicare Part D Formulary PR Newswire +7.81%
Oct-30-17 11:43AM  ETFs with exposure to Egalet Corp. : October 30, 2017 Capital Cube
06:02AM  Egalet to Present at Upcoming Scientific and Investor Conferences PR Newswire
Oct-25-17 06:02AM  Egalet to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on November 8, 2017 PR Newswire
Oct-24-17 09:00AM  Egalet (EGLT): The Guardian of Misuse and Abuse Zacks Small Cap Research
Oct-20-17 10:11AM  ETFs with exposure to Egalet Corp. : October 20, 2017 Capital Cube
Oct-09-17 11:28AM  ETFs with exposure to Egalet Corp. : October 9, 2017 Capital Cube
Oct-06-17 09:13AM  Egalet Corp. :EGLT-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-18-17 06:02AM  National Lacrosse League and Egalet Corporation Announce Educational Partnership Around A Non-Narcotic Pain Option and Responsible Pain Management PR Newswire
Sep-08-17 06:02AM  Egalet Presented New Data at PAINWEEK Demonstrating Potential of ARYMO ER to Deter Opioid Abuse PR Newswire +6.87%
Sep-06-17 06:02AM  Egalet to Present at Investor Conferences this Fall PR Newswire
Sep-05-17 06:02AM  Egalet's Partner Ascend Therapeutics® U.S., LLC Begins Promotion of SPRIX® Nasal Spray PR Newswire
Aug-29-17 04:02PM  Egalet Announces Scientific Presentations at PAINWeek 2017 Meeting PR Newswire
Aug-16-17 10:10AM  Edited Transcript of EGLT earnings conference call or presentation 9-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-17 10:03PM  Egalet reports 2Q loss Associated Press
05:20PM  Egalet trims non-sales workforce by 40% American City Business Journals
04:02PM  Egalet Announces Second Quarter 2017 Financial Results and Expense Reduction Plan PR Newswire
10:30AM  Investor Network: Egalet Corporation to Host Earnings Call ACCESSWIRE
Jul-26-17 06:02AM  Egalet to Host Conference Call and Webcast on August 9, 2017 to Discuss Second Quarter 2017 Financial Results PR Newswire
Jul-11-17 04:02PM  Egalet Announces Closing of $30 Million Public Equity Offering PR Newswire +5.67%
Jul-06-17 09:24AM  Egalet Announces Pricing of Public Offering of Common Stock and Warrants PR Newswire -35.83%
08:50AM  3 Stocks to Watch on Thursday: Egalet Corp (EGLT), Herman Miller, Inc. (MLHR) and PriceSmart, Inc. (PSMT) InvestorPlace
07:45AM  Egalet's stock plunges toward record low after stock offering plan MarketWatch
Jul-05-17 04:01PM  Egalet Announces Proposed Public Offering of Common Stock and Warrants PR Newswire +6.28%
Jun-20-17 10:15AM  Egalet Stumbles Over FDA Complete Response Letter 24/7 Wall St. -17.77%
09:06AM  Egalet Receives Complete Response Letter from U.S. Food and Drug Administration for Prior Approval Supplement for 10 mg and 15 mg Dosage Strengths of OXAYDO PR Newswire
Jun-08-17 01:33PM  ETFs with exposure to Egalet Corp. : June 8, 2017 Capital Cube -7.03%
Jun-07-17 08:00AM  Today's Research Reports on Stocks to Watch: Egalet Corporation and 22nd Century Group Accesswire -6.91%
06:02AM  Egalet Partners with Ascend Therapeutics® U.S., LLC to Co-Promote SPRIX® Nasal Spray PR Newswire
Jun-06-17 06:02AM  Egalet Announces ARYMO® ER Added to Large Payer Formulary PR Newswire +17.02%
Jun-05-17 02:40PM  Patents piling up for Wayne maker of abuse-deterrent medicines American City Business Journals -5.24%
06:02AM  Egalet Announces Issuance of New U.S. Patent for Guardian Technology PR Newswire
May-26-17 01:06PM  ETFs with exposure to Egalet Corp. : May 26, 2017 Capital Cube
May-18-17 04:02PM  Egalet Announces Results of ARYMO® ER Harm Reduction Modeling Analysis PR Newswire
May-17-17 06:02AM  Egalet Announces ARYMO ER Data Published in Journal of Opioid Management and American Journal of Drug and Alcohol Abuse PR Newswire
May-15-17 03:38PM  ETFs with exposure to Egalet Corp. : May 15, 2017 Capital Cube
06:02AM  Egalet Announces Scientific Presentations at American Pain Society Meeting PR Newswire
May-12-17 11:24AM  Egalet Corp. :EGLT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube +10.18%
May-11-17 07:20AM  Panel of Leading Pain Management Specialists Highlight Potential Role of Abuse-Deterrent Formulations of Opioids and Non-Narcotics to Help Curb Misuse and Abuse at Egalet Investor Day PR Newswire -8.33%
May-10-17 06:22AM  Egalet reports 1Q loss Associated Press
06:02AM  Egalet Reports First Quarter 2017 Financial Results PR Newswire
Apr-26-17 06:02AM  Egalet to Report First Quarter 2017 Financial Results During Investor Day on May 10, 2017 in New York PR Newswire
Apr-18-17 06:23AM  Egalet Announces U.S. Food and Drug Administration Acceptance of File for Prior Approval Supplement for OXAYDO® (oxycodone HCl, USP) tablets C-II 10 mg and 15 mg Dosage Strengths PR Newswire
Apr-10-17 04:02PM  Egalet Corporation Announces Changes to Board of Directors PR Newswire
Apr-03-17 06:02AM  Egalet to Participate in Spring Investor Conferences PR Newswire
Mar-30-17 06:02AM  Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO ER PR Newswire
Mar-29-17 02:35PM  The FDA News That Put The Wind Beneath Egalet Stock's Wings Benzinga +5.37%
11:25AM  Egalet Can Tout Abuse-Deterrent Opioid Painkiller Investopedia
11:25AM  Egalet Can Tout Abuse-Deterrent Opioid Painkiller at Investopedia
10:48AM  Egalet Corporation (Nasdaq: EGLT) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
07:33AM  EGALET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
06:02AM  Egalet Announces U.S. Food and Drug Administration Does Not Object to Egalet's Distribution of Materials and Communications to Healthcare Professionals Regarding Abuse-Deterrent Properties of ARYMO ER via Intranasal Route PR Newswire
Mar-28-17 10:34AM  DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders it Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation, Sets Lead Plaintiff Deadline of March 28, 2017 - EGLT Accesswire
10:10AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline - March 28, 2017 GlobeNewswire
Mar-24-17 08:50PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm GlobeNewswire
04:40PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT PR Newswire
01:17PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation PR Newswire
08:15AM  Blog Coverage Egalet Receives New US and International Patents for Guardian(TM) Technology Accesswire
Mar-23-17 11:05AM  Egalet Gets 4 New Patents for Guardian Technology at Investopedia
06:02AM  Egalet Announces Issuance of New U.S. and International Patents for Guardian Technology PR Newswire
Mar-21-17 11:25AM  INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:14AM  EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017 GlobeNewswire
05:17AM  Pain Therapeutics Remoxy ER Secures FDA Regulatory Guidance (PTIE,EGLT) at Investopedia
Mar-20-17 01:41PM  Nektar Pharma Opioid Drug Shows Promise In Phase 3 at Investopedia
11:33AM  Egalet Corp. :EGLT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
10:11AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline - March 28, 2017 Accesswire
10:10AM  SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-17-17 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT Accesswire
01:04PM  EGALET CORP Financials
11:30AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation GlobeNewswire
Mar-15-17 01:54PM  Egalet Corp. :EGLT-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
11:28AM  SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:38AM  How Endo's FDA Committee Vote Affects Egalet
10:17AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline - March 28, 2017 Accesswire
Mar-14-17 12:19PM  INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-13-17 08:57PM  Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation - EGLT Accesswire
05:23PM  EGALET CORP Files SEC form 10-K, Annual Report
01:45PM  For Egalet, Clinical Delays Outweigh Solid Q4 And Arymo Launch
12:26PM  Egalet Gets Grilled On Earnings Call By Unverified Caller
11:53AM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
10:38AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation Business Wire
Mar-11-17 06:17PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Mar-10-17 08:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT Accesswire
03:47PM  EGLT ALERT: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action EGLT GlobeNewswire
01:20PM  And the winner is? Who took home life sciences industry awards last night at bizjournals.com
10:50AM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm Accesswire
Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shea Patrick MChief Commercial OfficerOct 02Sale1.309101,18337,930Oct 03 05:02 PM
Strobeck MarkChief Operating OfficerOct 02Sale1.298,70011,22312,080Oct 03 05:03 PM
Musial StanChief Financial OfficerJul 03Sale2.363,4808,21342,407Jul 06 04:49 PM
Shea Patrick MChief Commercial OfficerJul 03Sale2.359102,13938,840Jul 06 04:48 PM
VARKI PAULSVP, GC & Chief Compliance OffJul 03Sale2.358061,89429,514Jul 06 04:47 PM
Strobeck MarkChief Operating OfficerJun 30Sale2.398,70020,79320,780Jul 05 06:26 PM
Musial StanChief Financial OfficerApr 03Sale5.048,61343,41045,887Apr 05 05:03 PM
VARKI PAULSVP, GC & Chief Compliance OffApr 03Sale5.058064,07028,820Apr 04 05:05 PM
Strobeck MarkChief Operating OfficerMar 31Sale5.118,70044,45729,480Mar 31 07:52 PM
Dayno Jeffrey M.Chief Medical OfficerMar 31Sale5.165362,76618,212Apr 04 05:05 PM
Shea Patrick MChief Commercial OfficerMar 20Sale4.754,25020,18838,250Mar 21 04:20 PM
Dayno Jeffrey M.Chief Medical OfficerJan 03Sale7.755364,15418,748Jan 04 04:59 PM
VARKI PAULSVP, GC & Chief Compliance OffJan 03Sale7.758066,24729,626Jan 04 04:58 PM
Musial StanChief Financial OfficerJan 03Sale7.7313,480104,20054,500Jan 04 04:57 PM
Strobeck MarkChief Operating OfficerDec 30Sale7.818,70067,94738,180Jan 04 04:55 PM